Abenex Invests in Groupe ESCG to Accelerate Expansion

Abenex Invests in EDL (Edition et Développement Logiciels) to Accelerate Growth

May 11, 2021

Software

Abenex has become a new shareholder in EDL (Edition et Développement Logiciels), the French developer of Xplore, a RIS/PACS and medical-imaging software suite, to support the company’s development, governance structuring and international expansion. The investment will back EDL’s organic growth and targeted acquisitions while facilitating a leadership transition as one founder steps back from operational duties.

Abenex Invests in Squad as Apax Partners Development Exits

January 12, 2021

Cybersecurity

French private equity firm Abenex has acquired a stake in Squad, a Paris‑headquartered cybersecurity and DevOps consultancy, as Apax Partners Development sells its participation. The transaction preserves founder and management ownership (founders Eric Guillerm and Marc Brua and 15 partner‑executives) and provides Squad with capital to support organic growth and future acquisitions.

Abenex Continuation Fund Acquires Majority Stake in Europa Group; Europa Acquires APM International

April 29, 2024

Healthcare Services

Abenex closed an oversubscribed continuation fund (~€300m) to acquire a majority stake in Europa Group from its Abenex V portfolio, making Abenex the group's majority shareholder while founders remain significant owners and management continues. As part of its buy-and-build strategy supported by the recapitalization, Europa Group also acquired APM International (a France-based healthcare press agency) to strengthen its medical information and publishing capabilities.

Abenex Invests in Santis LAB

September 23, 2024

Food & Beverage

Abenex has completed a minority growth investment in Santis LAB, a Franco‑Swiss laboratory that develops and markets food supplements sold through a network of roughly 2,000 pharmacies. The founders and management will remain operational and are investing alongside Abenex to support Santis' expansion into adjacent markets and new geographies.

Laboratoires Lehning Acquires Laboratoire Lescuyer from Abenex

October 1, 2020

Pharmaceuticals

Groupe Lehning (Laboratoires Lehning) has acquired French dietary-supplements maker Laboratoire Lescuyer from private equity firm Abenex; Abenex and co-investors Bpifrance and Ouest Croissance sold their entire stakes. Isabelle de Carmantrand and the Lescuyer family reinvested alongside the buyer; the deal is intended to combine complementary therapeutic areas and distribution channels to accelerate brand growth.

Abenex Acquires Origin Group (industrial sealing solutions)

September 30, 2022

Manufacturing

Abenex has acquired Origin Group, a Rhône‑Alpes based designer, manufacturer and distributor of industrial sealing solutions, from Initiative & Finance, Elige Capital and one of the founding families, with management led by Bertrand Sée joining the capital. Origin Group generates approximately €30 million in annual sales; Abenex intends to accelerate market consolidation through external growth to build a leading player in the industrial sealing market.